{"SPADE_UN_18794": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_18794", "Peptide Name": "GLRC-8 (Synthetic AMPs, variant of GLR-19, Arg-rich; Leu-rich; 1S=S, UCSS1a)", "Source": "De novo designed, man-made sequences", "Family": "Not found", "Gene": "Not found", "Sequence": "GLRCLRLRGRLRLGRCLLR", "Sequence Length": 19, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2280.86, "PI": 12.0, "Hydrophobicity": -0.06, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2011", "Reference": "J AIDS Clinic Res S2:003. doi:10.4172/2155-6113.S2-003.Wang HIV screen project", "Title": "De Novo Design of Antiviral and Antibacterial Peptides with \nVarying Loop Structures"}], "Frequent Amino Acids": "LRG", "Absent Amino Acids": "ADEFHIKMNOPQSTUVWY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 9, "Positive Residues": 7, "Negative Residues": 0, "Net Charge": 7, "Comments": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (80.95%) toGLRC-2. R: 37%; L: 37%.Chemical modification:  one disulfide bond C4-C16.Activity: inhibited E. coli (MIC 30 uM); B. subtilis (MIC 15-30 uM).Toxicity: TC50 31 ug/ml in CEM-SS cells.UPdated 6/2024", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18789", "Similarity": 1.0, "Sequence": "GLRCRLGRLLRRLGRCLLR"}, {"SPADE_ID": "SPADE_UN_18793", "Similarity": 1.0, "Sequence": "GLRCRLGRLLRRLGRC"}, {"SPADE_ID": "SPADE_N_10919", "Similarity": 1.0, "Sequence": "LRLR"}]}}}